Newsletter 04/2014


ECRD conference May 8-10th, Berlin :: Charity Testing Program :: Patient organizations' support

CENTOGENE is present at the ECRD in Berlin (May 8-10, 2014)

Meet our experts at booth # 6 - CENTOGENE will be actively participating at “The European Conference on Rare Diseases & Orphan Drugs” (ECRD), which takes place in the Andel’s Hotel in Berlin from May 8-10, 2014. ECRD is the main event where everyone from patients, to policy makers, healthcare professionals, industry, payers, regulators and academics are given the opportunity to meet, exchange information and ideas and join together in the fight against rare diseases. More information on the ECRD can be found here.

Visit our exhibition booth # 6 to discuss custom-tailored service from genetic testing to disease monitoring to disease prevention in a personal meeting with one of CENTOGENE's experts.

CENTOGENE’s Charity Testing Program

At CENTOGENE we assess each individual patient situation with the utmost responsibility, dedicated to offer the greatest medical benefit to every patient.

Testing for rare hereditary diseases is becoming more important but also a common diagnostic tool, especially as newer and more effective options for the treatment of certain diseases have become available.
Most insurance carriers cover genetic testing services – but each situation is unique. If a patient is uninsured or unable to cover the costs otherwise, CENTOGENE is offering genetic testing at no charge on a research basis through our CENTOGENE Charity Testing Program (CCTP).

Please do not hesitate to contact us anytime for any questions.

CENTOGENE supports patient organizations and rare disease foundations

  • Thinking today about tomorrow.
  • Caring for people through reliable genetic testing.
  • Helping your patients and their families make decisions about the right therapy option.

The continuous support of rare disease patient organizations is a genuine goal of CENTOGENE in its sustainable efforts to ease the lives of patients suffering from rare diseases. One of this year's beneficiary is the “Regroupement québécois des maladies orphelines” (RQMO / Quebec Coalition of Orphan Diseases) in Quebec, Canada. RQMO offers a bilingual and professional information and support service for individuals affected by any rare disease, caregivers and health professionals through its “Rare Disease Info Portal”.

CENTOGENE will be pleased to support further. Contact data and contact persons can be sent to us for further discussions and assessment of collaboration potentials.

Please feel free to contact us anytime.

If you have any questions or comments, please do not hesitate to contact us

Best regards,

Doreen Niemann
Senior Director Strategic Communication
Centogene AG


Centogene AG
Schillingallee 68
18057 Rostock


Responsible: Doreen Niemann
USt-IdNr.: DE813228872